06 Sep 2023
07:30 CEST |
THERAVET |
TheraVet Reports Its 2023 Half-year Results and Provides an Update on the Development of Its Activities
|
20103015 Pharmaceuticals |
Sales |
06 Sep 2023
07:30 CEST |
THERAVET |
TheraVet publie ses résultats financiers du 1er semestre 2023 et fait le point sur le développement de ses activités
|
20103015 Pharmaceuticals |
Sales |
11 Jul 2023
07:30 CEST |
THERAVET |
TheraVet provides an update on its 2023 half-year development and portfolio strategy
|
20103015 Pharmaceuticals |
New |
11 Jul 2023
07:30 CEST |
THERAVET |
TheraVet fait le point sur son développement et sa stratégie de portefeuille au premier semestre 2023
|
20103015 Pharmaceuticals |
New |
15 Jun 2023
07:30 CEST |
THERAVET |
TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago
|
20103015 Pharmaceuticals |
Other subject |
15 Jun 2023
07:30 CEST |
THERAVET |
TheraVet annonce une augmentation de 300 % du nombre de centres participant au programme dédié à l’ostéosarcome depuis son lancement il y a six mois
|
20103015 Pharmaceuticals |
Other subject |
31 May 2023
07:30 CEST |
THERAVET |
TheraVet annonce le lancement commercial d'un substitut osseux à libération locale et prolongée d'antibiotiques
|
20103015 Pharmaceuticals |
Products and services |
31 May 2023
07:30 CEST |
THERAVET |
TheraVet Announces the Commercial Launch of a Local and Sustained Antibiotic Releasing Bone Substitute
|
20103015 Pharmaceuticals |
Products and services |
04 May 2023
07:30 CEST |
THERAVET |
TheraVet Continues the Assessment of BIOCERA-VET in a New Clinical Program
|
20103015 Pharmaceuticals |
Other subject |
04 May 2023
07:30 CEST |
THERAVET |
TheraVet poursuit l'évaluation de BIOCERA-VET dans un nouveau programme clinique
|
20103015 Pharmaceuticals |
Other subject |
25 Apr 2023
07:30 CEST |
THERAVET |
TheraVet publie ses résultats annuels pour l’exercice 2022 et met à disposition les documents préparatoires pour l’Assemblée Générale du 1er juin 2023
|
20103015 Pharmaceuticals |
Sales |
25 Apr 2023
07:30 CEST |
THERAVET |
TheraVet reports Full-Year 2022 Financial Results and provides the preparatory documents for the General Assembly of June 1st, 2023
|
20103015 Pharmaceuticals |
Sales |
06 Apr 2023
07:30 CEST |
THERAVET |
TheraVet Launches its Osteosarcoma Reference Centers Program
|
20103015 Pharmaceuticals |
Other subject |
06 Apr 2023
07:30 CEST |
THERAVET |
TheraVet annonce le lancement de son programme de Centres de Référence dédié à l'Ostéosarcome
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2023
07:30 CEST |
THERAVET |
TheraVet Updates on Its Development and Portfolio Strategy
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2023
07:30 CEST |
THERAVET |
TheraVet fait le point sur sa stratégie de développement et de portefeuille produits
|
20103015 Pharmaceuticals |
Other subject |
21 Feb 2023
07:30 CET |
THERAVET |
TheraVet Signs an International Distribution Agreement for BIOCERA-VET® Covering 24 Countries
|
20103015 Pharmaceuticals |
News contracts |
21 Feb 2023
07:30 CET |
THERAVET |
TheraVet signe un accord de distribution à l’international pour BIOCERA-VET® couvrant 24 pays
|
20103015 Pharmaceuticals |
News contracts |
15 Feb 2023
17:45 CET |
THERAVET |
TheraVet Announces the Start of the Assessment of BIOCERA-VET® in Horse Bone Cyst
|
20103015 Pharmaceuticals |
Other subject |
15 Feb 2023
17:45 CET |
THERAVET |
TheraVet annonce le début de l'évaluation de BIOCERA-VET® dans le traitement du kyste osseux chez le cheval
|
20103015 Pharmaceuticals |
Other subject |
12 Dec 2022
07:30 CET |
THERAVET |
TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range
|
20103015 Pharmaceuticals |
News contracts |
12 Dec 2022
07:30 CET |
THERAVET |
TheraVet optimise sa stratégie commerciale en France avec un nouvel accord de distribution pour sa gamme BIOCERA-VET®
|
20103015 Pharmaceuticals |
News contracts |
07 Dec 2022
07:30 CET |
THERAVET |
TheraVet : BIOCERA-VET® nominé au Prix de l’Innovation Vétérinaire (AFVAC 2022)
|
20103015 Pharmaceuticals |
Other subject |
07 Dec 2022
07:30 CET |
THERAVET |
TheraVet: BIOCERA-VET® Nominated for the Veterinary Innovation Award (AFVAC 2022)
|
20103015 Pharmaceuticals |
Other subject |
26 Sep 2022
07:30 CEST |
THERAVET |
TheraVet annonce un accord de distribution exclusif pour BIOCERA-VET® aux États-Unis
|
20103015 Pharmaceuticals |
News contracts |
26 Sep 2022
07:30 CEST |
THERAVET |
TheraVet Announces an Exclusive Distribution Agreement for BIOCERA-VET® in the USA
|
20103015 Pharmaceuticals |
News contracts |
19 Sep 2022
07:30 CEST |
THERAVET |
TheraVet annonce sa participation au congrès de l’ESVOT 2022 avec 3 communications scientifiques
|
20103015 Pharmaceuticals |
Meetings / events |
19 Sep 2022
07:30 CEST |
THERAVET |
TheraVet Announces Its Participation in the 2022 ESVOT Congress With 3 Scientific Communications
|
20103015 Pharmaceuticals |
Meetings / events |
09 Sep 2022
07:30 CEST |
THERAVET |
TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities
|
20103015 Pharmaceuticals |
Other subject |
09 Sep 2022
07:30 CEST |
THERAVET |
TheraVet publie ses résultats financiers du 1er semestre 2022 et fait le point sur le développement de ses activités
|
20103015 Pharmaceuticals |
Other subject |
30 Jun 2022
17:45 CEST |
THERAVET |
TheraVet Provides Its 2022 First Half-year Operational Update
|
20103015 Pharmaceuticals |
Other subject |
30 Jun 2022
17:45 CEST |
THERAVET |
TheraVet publie son point d’activité du 1er semestre 2022
|
20103015 Pharmaceuticals |
Other subject |
30 Jun 2022
07:30 CEST |
THERAVET |
TheraVet Annonces the Commercial Launch of its BIOCERA-VET Product Line in the United States of America
|
20103015 Pharmaceuticals |
Other subject |
30 Jun 2022
07:30 CEST |
THERAVET |
TheraVet annonce le lancement commercial de sa gamme de produits BIOCERA-VET® aux États-Unis
|
20103015 Pharmaceuticals |
Other subject |
02 Jun 2022
07:30 CEST |
THERAVET |
TheraVet Annonces the Commercial Launch of the Most Comprehensive Line of Bone Substitutes in the Veterinary Market
|
20103015 Pharmaceuticals |
Other subject |
02 Jun 2022
07:30 CEST |
THERAVET |
TheraVet annonce le lancement de la gamme de substituts osseux la plus complète pour le marché vétérinaire
|
20103015 Pharmaceuticals |
Other subject |
30 May 2022
07:30 CEST |
THERAVET |
TheraVet Signs a Distribution Agreement With Nuzoa, a Leading Spanish Company in the Distribution of Veterinary Products and Services
|
20103015 Pharmaceuticals |
Other subject |
30 May 2022
07:30 CEST |
THERAVET |
TheraVet signe un accord de distribution avec Nuzoa, une société espagnole leader dans la distribution de produits et services vétérinaires
|
20103015 Pharmaceuticals |
Other subject |
12 May 2022
07:30 CEST |
THERAVET |
TheraVet: General Meeting of June 2, 2022: Availability of Preparatory Documents
|
20103015 Pharmaceuticals |
Other subject |
12 May 2022
07:30 CEST |
THERAVET |
TheraVet : Assemblée générale du 2 juin 2022 : mise à disposition des documents préparatoires
|
20103015 Pharmaceuticals |
Other subject |
10 May 2022
07:30 CEST |
THERAVET |
TheraVet signe un important accord de distribution avec le distributeur d’instruments orthopédiques et chirurgicaux Veterinary Instrumentation
|
20103015 Pharmaceuticals |
Other subject |
10 May 2022
07:30 CEST |
THERAVET |
TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation
|
20103015 Pharmaceuticals |
Other subject |
06 Apr 2022
07:30 CEST |
THERAVET |
TheraVet publie ses résultats annuels de l’exercice 2021 et confirme ses perspectives ambitieuses de développement et de commercialisation pour 2022
|
20103015 Pharmaceuticals |
Other subject |
06 Apr 2022
07:30 CEST |
THERAVET |
TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2022
07:30 CEST |
THERAVET |
TheraVet: Market-making Agreement with Banque Rothschild
|
20103015 Pharmaceuticals |
Other subject |
28 Mar 2022
07:30 CEST |
THERAVET |
TheraVet : Mise en œuvre d’un contrat d’animation de marché avec la banque Rothschild
|
20103015 Pharmaceuticals |
Other subject |
15 Mar 2022
07:30 CET |
THERAVET |
TheraVet: Commercial Launch of BIOCERA-VET® in United Kingdom and Ireland
|
20103015 Pharmaceuticals |
Other subject |
15 Mar 2022
07:30 CET |
THERAVET |
TheraVet : Lancement commercial de BIOCERA-VET® au Royaume-Uni et en Irlande
|
20103015 Pharmaceuticals |
Other subject |
07 Feb 2022
07:30 CET |
THERAVET |
TheraVet élargit son portefeuille de substituts osseux avec une gamme innovante de greffons biologiques
|
20103015 Pharmaceuticals |
Other subject |
07 Feb 2022
07:30 CET |
THERAVET |
TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts
|
20103015 Pharmaceuticals |
Other subject |